Free Newsletter

  Email address:
   

Site Search

Bird Flu Vaccine from Sinovac Reports Success

publication date: Dec 24, 2007
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Sinovac Biotech Ltd. released positive data from a Phase II clinical trial of its pandemic flu (H5N1) vaccine. In the stratified, randomized, double-blind test, the top two dosage levels of Sinovac’s vaccine met the EMEA evaluation standards for seasonal flu vaccines. The trial did not discover any safety problems. Sinovac said it would use the Phase II results of the whole viron vaccine to determine dosing levels for the Phase III tests. More details...

Stock symbol: (AMEX: SVA)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

 

 
   
ChinaBio Events

October 24, 2008
Beijing, China

>> More details...

Partner Events
 
October 11-13, 2008
Dalian, China
 
November 08, 2008
The Institute of Americas, UCSDa
 
November 9-11, 2008
Shanghai, China
 
February 23-25, 2009
San Diego

>> More details...

Partners